Tevogen Bio Holdings INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Tevogen Inc. reports a restricted stock award to Ryan Saadi, contingent on achieving $1 billion in revenue within a five-year performance period.
NASDAQ
Kirti Desai amends Schedule 13D to report a restricted stock award of 750,000 shares contingent on achieving $1 billion in revenue.
NASDAQ
Ryan Saadi, CEO of Tevogen Bio Holdings Inc., reports increased beneficial ownership following a restricted stock grant.
NASDAQ
Ryan H. Saadi, founder of Tevogen Bio Holdings Inc., updated his beneficial ownership to 62% after gifting 460,000 shares to charitable entities.
NASDAQ
Tevogen Bio Holdings Inc. CEO Ryan Saadi increased his beneficial ownership to 64.5% with a new 8 million share restricted stock grant, while also disclosing a recent sale of over 1.4 million shares.